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Differential expression of elastin assembly genes in
patients with Stanford Type A aortic dissection
using microarray analysis
Bernice L. Y. Cheuk, PhD and Stephen W. K. Cheng, MSc, FRCS, FACS, Hong Kong, China
Objective: Pathologic studies have demonstrated that aortic dissection is initiated by an intimal tear, followed by the rapid
growth of an intramural hematoma that dissects the media and is characterized by elastin degradation. Genetic
extracellular matrix abnormalities and proteinases may be the predisposing factors in aortic dissection, but little is known
about the role of elastic fiber assembly. Fibulin-1 is an extracellular protein that is expressed in the vascular basement
membrane. It regulates elastic fiber assembly and hence provides integrity in aortic structure. This study investigates the
expression profiles of genes responsible for the elastolysis in the dissected human aorta, especially those coding fibulin-1,
matrix metalloproteinase-9 (MMP-9), and elastin.
Methods: Intraoperative aortic samples were obtained from Chinese patients with Stanford Type A aortic dissection. Both the
ascending dissected aortas (primary tear) and the adjacent intact aortas were collected for comparison. Control aortic tissues
were obtained from healthy organ donors. The gene profile study was determined by the Affymetrix HG-U133A GeneChip
(Affymetrix, Santa Clara, Calif) and analyzed by GeneSpring GX11.0 (Agilent Technologies Inc, Palo Alto, Calif). Only the genes
displaying a net signal intensity two-fold higher than the mean background were used for analysis. To evaluate elastin expression,
aortic sections were stained with Movat pentachrome stain. Fibulin-1, MMP-9, and elastin mRNA and protein expression were
further confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) and immunoblotting, respectively.
Results: Eightmale Chinese aortic dissection patients (mean age, 45.8 years) and eight gender- and age-matched organ donors
were recruited for the study. On the Affymetrix platform, 2,250 of 22,283 genes (10.1%) were detectable. The dissected and
adjacent macroscopically intact aorta displayed similar gene expression patterns. In contrast, 11.2% (252) of the detectable
genes were differentially expressed in the dissected and control aortas. Of these, 102 genes were upregulated, and 150 genes
were downregulated. Based on the gene ontology, genes that code for extracellular matrix protein components and regulating
elastic fiber assembly, like fibulin-1 and elastin, were downregulated, while enzymes like MMP-9 and MMP-11 that degrade
matrix proteins were upregulated in dissected aortas. RT-PCR and Western blot results further validated the results.
Conclusions: Our gender- and age-matched study demonstrated that the alternated genes in the elastin assembly of dissected
aortas may predispose structural failure in the aorta leading to dissection. However, no significant gene alterations in the
adjacent intact and dissected aortas of the same patient can be found. Therefore, the genetic changes found in the dissected
aortas most likely developed before the dissection starts. The inhibition of the aberrant expression of the fibulin-1 gene and
that of the related matrix proteinase may open a new avenue for preventing aortic dissection. (J Vasc Surg 2011;53:1071-8.)
Clinical Relevance: Thoracic aortic dissection is a catastrophic separation of the layers within the aortic wall. The freshly
torn aorta is severely weakened andmay rupture, which results in death. The traditional treatment of this life-threatening
disease usually requires surgery, but the morbidity and mortality remain unsatisfactory. Besides heritable connective
tissue diseases and hypertension, themajority of aortic dissections develop without any recognizable reason. Dysregulated
extracellular matrix protein like elastin and collagen characterized the thoracic aortic dissection, but still little is known
about the genetics of the disease. With the development of the Affymetrix cDNA array platform that can simultaneously
analyze the expression level of over 47,000 transcripts per tissue, comparison of altered gene expression patterns in
diseased and nondiseased tissue were warranted in the present study, and we can hope to have a better understanding of
the pathogenesis of this aortic disorder. The inhibition of the aberrant expression of the matrix gene and the related
proteinases may also open a new avenue for preventing aortic dissection.
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involves the separation of the layers within the aortic
wall. Traditional treatment of Stanford Type A aortic
dissection usually requires surgery, but the rate of mor-
bidity and mortality remain undesirably high. Pathologic
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April 20111072 Cheuk and Chengwithin the aortic walls.1,2 The freshly torn aorta is then
severely weakened and may rupture.
Elastin is an extracellular matrix protein found in aortas
imparting elasticity to connective tissue that is necessary for
the aorta to absorb pulse pressure.3 It is secreted as tro-
poelastin, a soluble protein that is cross-linked in the tissue
space to form an insoluble elastin matrix. Cross-linked
elastin can be found in association with fibrillin-1, fibrillin-
2, and fibulin-1, suggesting that these proteins contribute
to aortic structural integrity by elastic fiber assembly, struc-
ture, or function. MMPs are responsible for the elastolysis.
Clinical data have suggested that tissue remodeling involv-
ing MMPs is an important pathologic event in aortic dis-
section,1,4 but the pathological significance of elastin de-
generation within the dissected aortic wall remains poorly
understood.
The fibulins are a newly abundantly in the basement
membrane of blood vessels.5 Among them, fibulin-1 is
essential for elastin polymerization. Tropoelastin cannot be
assembled into mature elastin fibrils without the functional
fibulin-1.5 In adult blood vessels, pronounced fibulin 1
deposition can be found in the matrix that surrounds
vascular smooth muscle cells and in the elastic laminae of
arteries.6 Fibulin-1 deficiency in mice causes extensive
hemorrhaging and perinatal death.7 Another study has also
shown that patients with unstable angina pectoris and acute
myocardial infarction have significantly reduced levels of
plasma fibulin-1.8 These findings have led to the specula-
tion that plasma fibulin-1 may be transferred to or con-
sumed in or around the atherosclerotic lesion. In addition,
fibulin-1 has been incorporated into fibrin clots that are
associated with atherosclerotic lesions.9 Findings from
DNA microarray studies showed that fibulin-1 is consis-
tently associated with MMP-2 expression in cancer.10
Thus, altered patterns of fibulin-1 and MMP gene expres-
sion suggest a pre-existing structural failure of the aortic
wall, which may lead to dissection.
The Affymetrix (Affymetrix, Santa Clara, Calif) plat-
form is very sensitive in detecting signals corresponding to
expressed mRNAs that contains 54,675 probe sets that can
analyze the expression level of over 47,000 transcripts.
Until now, only one German institute study has examined
the gene profiles of the dissected and adjacent macroscop-
ically intact aorta using the Atlas human broad array, with
3,537 genes being analyzed.11
In the present study, the significance of fibulin-1 and
the related MMPs in dissected aortic tissue was delineated
using the Affymetrix GeneChip oligonucleotide microarray
platform. We hypothesized that genes responsible for elas-
tin assembly-like, fibulin-1 expression are reduced in pa-
tients with Stanford Type A aortic dissection, and that its
reduction may accompany fragmentation of elastic fibers
due to the enhanced specific.
MMPs. The specific gene expression among dissected
aortas and adjacent nondissected aortas were also studied
and compared with normal aortas. The gene ontology of
the differentially expressed genes among the two groups of
aortas was also determined. Validity of interested genes and mroteins expression was confirmed by the semiquantitative
everse transcriptase polymerase chain reaction (RT-PCR)
ethod and Western blotting, respectively.
The findings of this study provide information on the
athogenesis of Stanford Type A aortic dissection. The
nhibition of the aberrant expression of the fibulin gene and
he related proteinases may open a new avenue for prevent-
ng aortic dissection.
ETHODS
Patient recruitment and tissue collection. Between
ay 2007 and May 2009, adult patients undergoing emer-
ent aortic reconstructive surgery on Stanford Type A dis-
ection who presented to the Grantham Hospital and Queen
ary Hospital were recruited for the study. Only patients with
dequate (with both primary tear and adjacent intact aorta)
nd good-quality pathologic specimens were chosen for sub-
equent analysis. Patients with known connective tissue disor-
ers such as Marfan syndrome and Ehlers-Danlos syndrome
ere excluded from the study. For comparison, specimens,
rom age- and gender-matched control patients with nor-
al aortas without atherosclerotic or vascular diseases, were
btained at transplantation organ procurement. Informed
onsent was obtained from all patients and organ donors’
elatives accordingly.
Processing of fresh aortic tissues. Each specimen
as divided into two pieces. The first piece was transferred
o RNA later solution (Qiagen, Hilden, Germany) imme-
iately after removal from the patient and stored at -80°C
ntil further processing. The remaining tissues were then
xed in 10% formalin for histologic examination.
Total RNA isolation. Tissues were first homogenized
y homogenizer (Qiagen) and then by the Trizol method
Invitrogen Life Technologies, Carlsbad, Calif) for the
otal RNA extraction following the manufacturer’s instruc-
ions. The extracted total RNA was then purified using the
Neasy Mini Kit column (Qiagen) with the DNase incu-
ation (Qiagen). Total RNA extracted was quantified using
n Eppendorf UV spectrophotometer, and the integrity of
he RNA samples was controlled using Agilent 2100 Bio-
nalyzer (Agilent Technologies Inc, Palo Alto, Calif) with
he RNA 6000 Nano Kit (Agilent Technologies Inc). Only
NAs with OD260/OD280  1.8 and an RNA integrity
umber (RIN) 8 were used for microarray experiments.
he remaining good-quality RNAs were kept for the sub-
equent RT-PCR confirmative experiments.
Microarray analysis. Each good-quality sample was
ybridized to the Affymetrix HG-U133 plus 2.0 GeneChip
Affymetrix). This gene chip analyzes the expression level of
8,500 well-characterized human genes. First, 10g of the
otal RNA was reverse-transcribed with the SuperScript
hoice System (Invitrogen) with oligo dT primers contain-
ng a T7 RNA polymerase promoter site. Then, cDNA was
n vitro transcribed and labeled with biotin using the IVT
abeling kit (Affymetrix) followed by the fragmentation of
he biotinylated cRNA. Next, the quality of this cRNA was
ssessed with the Agilent 2100 Bioanalyzer. The frag-
ented cRNA was hybridized overnight to Affymetrix
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Volume 53, Number 4 Cheuk and Cheng 1073Human Genome U133APlus 2.0 Arrays and scanned fol-
lowing the guidelines from Affymetrix (http://www.
affymetrix.com). The chips were washed and stained using
the GeneChip Fluidics Station 400 (Affymetrix) and then
scanned with the GeneChip Scanner 3000 (Affymetrix).
Data analysis. The resulting image files were analyzed
by Affymetrix GeneChip Operating Software (GCOS) ver-
sion 1.2. The global scaling technique was used to scale the
fluorescence intensity of each chip to a target signal of 500.
Different internal quality controls were used, including
Spike-In controls (BioB, BioC, BioD and Cre), a 3=–5=
ratio of GAPDH 3.0, and an average background signal
per probe set 100. Transcripts were considered as differ-
entially expressed when the following criteria were met: 1)
present (P) calls in all samples of the selected group; 2)
consistent decreased or increased change in expression for
pair-wise comparisons between the two selected groups; 3)
a mean absolute value of the signal log ratio 0.5 (which
equals a fold change ratio (FC) of two or higher); and 4) a
two-tailed unpaired Student’s t test with a significant result
(P  .05). As the Affymetrix platform is more precise and
sensitive than other arrays in detecting signals, the minimal
fold change was set to 2.0. Only genes with strong signals
of more than 90% of the mean signal of all spots on the array
were accepted as being expressed. The data files (CEL files),
resulting from analysis with the Affymetrix GCOS software,
were imported into GeneSpring GX 11.0 software (Agilent
Technologies Inc) for further data analysis. The probe level
intensities data were preprocessed using the robust multi-
array average algorithm (RMA; GeneSpring) for back-
ground adjustment, normalization, and log-transformation
of the perfect match values. Additionally, the data were
normalized per gene to the median. The normalized data
were then subjected to a principal components analysis.
PCA is an unsupervised decomposition method to reduce
multidimensional data into three dimensions. Each dimen-
sion represents a principal component with a certain per-
centage of variance. PCA recognizes patterns and clusters
in data sets in multiple dimensions, such as gene expression
data, and is as such a valuable visualization and summariz-
ing tool. The PCA algorithm in GeneSpring GX 11.0 was
applied to all samples, using the “all genes” (54,675) gene
list for the Affymetrix HG U133 Plus two genome. Only
the genes displaying a net signal intensity two-fold higher
Table I. Primer used for reverse transcriptase polymerase
Target mRNA
Fibulin-1 Sense primer 5=-A
Antisense primer 5=-C
MMP-9 Sense primer 5=-G
Antisense primer 5=-G
Elastin Sense primer 5=-C
Antisense primer 5=-A
-actin Sense primer 5=-G
Antisense primer 5=-G
MMP-9, Matrix metalloproteinase-9.than the mean background were used for further analysis. vGene ontology analyses. The genes identified by mi-
roarray analyses were used for gene ontology analyses.
ene accession numbers were imported into the Ingenuity
athway Analysis software (Ingenuity Systems, Mountain
iew, Calif). The genes were categorized based on loca-
ion, cellular components, and reported or suggested bio-
hemical, biological, and molecular functions using the
oftware.
Elastin staining. The fixed aortic walls were then
rocessed and embedded in paraffin wax. Paraffin embed-
ed sections (6 m thick) were cleared and rehydrated by
equential immersions in three changes of xylene, followed
y graded ethanol and distilled water. Aortic slides were
tained with hematoxylin and eosin (H&E) and Movat
entachrome, using standard laboratory protocols. All
tained sections were observed by microscopy.
RT-PCR analysis. The expression of interested genes
nvolved in elastin assembly was further analyzed semiquan-
itatively by RT-PCR. Specific primers used for amplifying
uman fibulin-1, MMP-9, and elastin were as stated in
able I. The remaining good-quality RNAs extracted from
oth dissected and normal aorta by Trizol Regent (Invit-
ogen) and cleaned by the RNeasy Midi Kit (Qiagen) were
nally reverse-transcribed to cDNA. First-strand cDNA
ynthesis was performed using 2 g of total RNA, 1 g of
ligo (dT) primers, 20 U RNase of inhibitor, and 50 U of
urine leukemia virus reverse transcriptase in a total vol-
me of 20 L according to the manufacturer’s protocol
Applied Biosystems, Foster City, Calif). The cDNA served
s the template for PCR amplification. -actin, a constitu-
ively expressed protein in mammalian cells, was used as an
nternal control gene and amplified in each tissue sample for
ormalization. Each PCR was performed in a 25-L reac-
ion volume with 0.5 U of Amplitaq DNA polymerase, 2
M MgCl2, 0.5 mM dNTP, and 1  PCR buffer. The
CR was carried out for 26 to 36 cycles, with each cycle
eing 45 seconds at 95°C, 60 seconds at 52°C to 65°C, and
0 seconds at 72°C. Under these conditions, the amplifi-
ation of all of the target genes and -actin were in the
inear range as demonstrated in a series of preliminary
xperiments by removing samples for analysis at cycles 20,
2, 24, 26, 28, 30, 32, 34, and 36. An aliquot of 8 L was
ithdrawn from each PCR reaction tube, resolved in 2%
garose gels in 1  Tris-borate-EDTA (TBE) buffer, and
reaction analysis
Primer sequences Product size
GCGAAGATATTGATGAGTG-3= 172 bp
CATCAATATCTTCGCAGGT-3=
AGATTGGGAACCAGCTGTA-3= 208 bp
CGCCTGTGTACACCCACA-3=
TAAGGCAGCCAAGTATGGA-3= 275 bp
CCAACCCCGTAAGTAGGAAT-3=
TCCTGCGTCTGGACCTGGCT-3= 181 bp
TGACCTGGCCGTCAGGCAGC-3=chain
CCT
ACT
CGG
ACG
CGC
GCT
CCA
TGAisualized by ethidium bromide. Bands observed were
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April 20111074 Cheuk and Chengquantified by densitometry, and densitometric analysis was
performed on the bands by use of image analysis software
(Bio-Rad Laboratories, Hercules, Calif). A negative control
(without template) was always included in each PCR step.
Relative expression levels of interested genes were calcu-
lated by dividing the expression level of target gents with
the expression level of -actin of the same RNA template.
Each PCR was performed in a 25-L reaction volume with
0.5 U of Amplitaq DNA polymerase, 2 mM MgCl2, 0.5
mM dNTP, and 1 PCR buffer. The PCR was carried out
for 26 to 36 cycles, with each cycle being 45 seconds at
95°C, 60 seconds at 52°C to 65°C, and 90 seconds at
72°C. An aliquot of 8 L was withdrawn from each PCR
reaction tube, resolved in 2% agarose gels in 1  TBE
buffer, and visualized by ethidium bromide. Bands ob-
served were quantified and densitometric analysis was per-
formed (Bio-Rad Laboratories).
Western blot analysis. Protein quantification analysis
of aortic tissues was done by Western blot. Each aortic
sample, which was stored in a freezer, was first thawed and
lysed in modified RIPA buffer (Tris 50mmol/L, NaCl 150
mmol/L, Triton 1%, ethylene glycol-bis [b-aminoethyl
ether], –N, N-tetraacetic acid [EGTA] 1 mmol/L, apro-
tinin 1 g/mL, leupeptin 1 g/mL). The total protein
concentration of each sample was determined using a Bio-
Rad protein assay with bovine serum albumin as the stan-
dard (Bio-Rad Laboratories). Heat-denatured samples
were resolved under reducing conditions by sodium dode-
cyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
using 10% polyacrylamide gels (30 g of total protein per
lane). Proteins were electrophoretically transferred to ni-
trocellulose and washed three times in 20 mmol/L Tris/
HCl, pH 7.5, 0.5 mol/L NaCl, 0.05% Tween 20 (TTBS).
Membranes were blocked overnight at 4°C in TTBS con-
taining 5% powdered milk. The proteins of interest were
revealed by incubating for 1 hour in TTBS  1% milk
containing specific anti-fibulin-1 (Santa Cruz Biotechnol-
ogy, Santa Cruz, Calif), anti-MMP9 (Santa Cruz) and
antielastin (Santa Cruz; recommended for the detection of
the precursor of tropoelastin and mature elastin). Mem-
branes were washed in TTBS  3% milk and incubated for
1 hour with horseradish-peroxidase conjugated goat anti-
mouse immunoglobulin G (IgG; Zymed, San Francisco,
Calif) diluted to 1/3,000 in TTBS 1% milk. Immunore-
active proteins bands were visualized on X-ray film (Amer-
sham, Bucks, UK) by enhanced chemiluminescence using
kit regents and instructions recommended by the manufac-
turer (Amersham). Densitometric analysis was performed
by use of image analysis software (Bio-Rad Laboratories).
Statistical evaluation. The fold change of the target
gene expression and the relative expression of expressed
genes and proteins among all aortic groups were compared
by the unpaired Student’s t test. A P value of 0.05 was
considered significant.
RESULTS
Patient groups and RNA quality. Within the study
period, only eight male aortic dissection patients were aelected from the overall patient group because of their
athologic specimen’s adequate and good RNA quality for
ubsequent microarray analysis. None of them was induced
y aortic coarctation and cardiovascular surgery. Eight age-
nd gender-matched control patients with normal aortas
ere chosen for comparison. The demographic data of the
atients are summarized in Table II.
Differential gene expression of dissected aortas de-
ermined by microarray analysis. Under such stringent
riteria (fold-change 2 and P  .05), only 252 gene
xpressions were significantly altered in dissected aortas as
ompared with normal aortas at the transcriptional level.
mong all the differentially expressed genes, 102 were
p-regulated in dissected aortas and the remaining genes
ere downregulated. Table III (online only) identifies all
ifferentially expressed genes in the microarray analysis
ith the corresponding functional groups. Some genes are
ot shown as no biological function can be identified yet.
The genes encoding the extracellular matrix protein
ere mostly downregulated in dissected aortas, with elastin in
articular being significantly decreased 3.51 times more in
issected aortas than normal aortas (P  .05). The level of
bulin-1 mRNA was also significantly lower in dissected aor-
as. So far, 29 types of collagen have been identified, and 13
ypes have been described in human. The types IV and VIII
ollagen were significantly downregulated in dissected aortas,
hereas types I, III, VI, X, and XI collagen were upregulated
n dissected tissues. Others collagen types were not signif-
cantly changed between the two groups.
The genes encoding extracellular matrix proteolysis,
pecifically MMP-9 and MMP-11, were highly expressed
n dissected aortas. In addition, gene expression of the
issue inhibitor of metalloproteinase 1 (TIMP1) and
etalloproteinase 2 (TIMP2) were down-regulated. The
enes encoding for inflammation and apoptosis were all
p-regulated, while genes encoding cytoskeleton pro-
eins were all down-regulated in dissected aortas.
This Affymetrix gene ontology annotation also showed
hat the differentially expressed genes involved in other bio-
ogical functions such as cell adhesion proteins, receptor,
mmunomodulatory, growth factors, protein turnover and
inding, nucleotide binding, stress response, cell growth and
ycle, vasomodulator, procoagulants, metabolism, transporter
able II. Patients’ demographic data
ortic type Control
Type A aortic
dissection
ge (mean) 46.1 years 45.8 years
ge (range) 31-56 years 37-59 years
ale 100% 100%
ypertension 12.5% 75%
ith medication (statins) 12.5% 50%
resented emergently 50% 100%
ortic diameter (mean) 3.05 cm 3.2 cm
ody mass index — 24.6 kg/m2
he mean age of the dissected aorta patients (45.8 years old) and organ
onor group (46.1 years old) was comparable.ctivity, translation, and transcriptional control.
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Volume 53, Number 4 Cheuk and Cheng 1075Pattern of gene expression in dissected and adjacent
nondissected aortas. On the Affymetrix platform, 2206
of 22,283 genes (9.9%) showed detectable expression sig-
nal in the nondissected aortic pieces of the same surgical
patient group. However, no significant differences of gene
expression were found between the two parts of the aortas.
Movat pentachrome staining of aortas. Fig 1, A
shows that the elastic fibers were always properly oriented
in control aortas. Laminar medial necrosis, inflammation,
and giant cells were not present in the entire cohort. In
contrast, medial degeneration was found in dissected aortas
(Fig 1, B-D). They were defined as the fragmentation and
loss of elastic fibers.
Validation of the differentially genes by semi-
quantitative RT-PCR. RT-PCR confirmed the results
that fibulin-1 and elastin were down-regulated, while the gene
encoding the MMP-9 was up-regulated in diseased aortas (Fig
2).
Confirmation of the protein level by immu-
noblotting. The Western blot analysis showed a similar
expression pattern of interested genes at posttranslation
levels (Fig 3). The relative expression of interested genes
(Fig 3, A) and the proteins (Fig 3, B) expression among
control aortas, dissected aortas, and nondissected aortas
was shown in Fig 4. No statistically significant difference of
the protein expression can be found between the dissected
aortas and nondissected aortas. Notably, the protein ex-
pression change showed a relatively higher value than gene
expression change in the target protein of fibulin-1 and
elastin, but not MMP-9.
DISCUSSION
In the present study, the array that contains more than
47,000 known human genes was employed to detect fold
changes in gene expression in dissected aortas compared
with those of control aortas. Thus, this comprehensive
comparison study of gene expression may help to identify
candidate genes for the pathogenesis of this aortic disease,
as the cause is still currently unclear.12
A total of 252 genes were differentially expressed in the
aortic wall of dissected aortas. Specifically, one of the extra-
(A)                            (B)                        
Fig 1. Elastic fiber fragmentation in control (A) an
pentochrome staining (under 200magnification). Usin
(blue), collagen (red), and muscle (yellow) were differ
architecture within the meidal layers with lower elastin
fragmentation was largely interlamellar and created “cystcellular matrixes, elastin, has decreased significantly and is accompanied by a diminished fibulin-1 and an enhanced
MP-9 level. Fibulin-1 is essential for the polymerization
f elastin13 and believed to participate in diverse extracel-
ular supramolecular structures in aorta that is widely dis-
ributed. It is able to bind fibronectin, proteoglycans, and
arious elastic fiber and basement membrane proteins. At
he same time, there is evidence of a regulatory function of
bulin-1, as it inhibits the activity of the extracellular signal-
egulated kinase, and thus the signal transduction.14
In addition, fibulin-1 is exhibits distinct interactions
ith collagen type IV,13 another matrix protein signifi-
antly downregulated in our dissected aorta. Both collagen
nd elastin are the most abundantly expressed extracellular
atrix proteins of the aortic wall, providing tensile strength
)                            (D) 
sected aortas (B, C, and D), was shown by Movat
s staining method, elastic fibers (blue-black color), nuclei
ly stained. The black bar indicates 5m. Destructive
tent was obvious in dissected aortas. The elastic fiber
ces” as evaluated by this staining method.
ig 2. Validation of microarray data by semiquantitative reverse
ranscriptase polymerase chain reaction (RT-PCR). The expression
atterns of fibulin-1, matrix metalloproteinase-9 (MMP-9), and
lastin were consistent with the expression pattern shown in mi-
roarray experiments. Here, -actin was used as housekeeping
ene, which was assessed for the relative abundance in both control
control 1-4) and aortic dissection tissues (AD1-4).    (C
d dis
g thi
ential
connd elasticity. Therefore, decreased fibulin-1 expression
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April 20111076 Cheuk and Chengmay contribute to the development of aortic dissection,
either by weakening the aortic connective tissue or by
altering the cellular signal transduction. It is also clear that
the transcriptional alteration of fibulin-1 identified in the
present study is confirmed at the protein level, therefore
supporting its functional relevance.
Another important alteration found in the dissected
aorta was the marked increased of both MMP-9 and -11, an
observation partly consistent with previous studies.12,14,15
Their result demonstrated that only either MMP-914 or
MMP-1112,15 is increased in Stanford Type A aortic dissec-
tions. MMP-9 lyses collagen IV and elastin, whereas
MMP-11 degrades fibronectin and proteoglycanes. Thus,
the increased local expression of those MMPs may play an
important role in the destructive stage for aortic dissection.
Systemic hypertension is one of the most important risk
factors for the disease.16 Damage to aortic tissue triggers
repair responses, and proper amounts of each extracellular
matrix are essential for the arterial integrity to withstand the
outward forces exerted by blood pressure.6 Under normal
physiological conditions, the extracellular matrix under-
goes constant metabolism, with a relatively low basic turn-
over rate. It is logical to assume that defects in elastin
predispose patients to dissection. The fragmentation and
decreased content of elastin have been implicated in aortic
dissection by most studies,17,18 including ours. The
smooth muscle cells in the medial layer where the dissection
occurs seem to produceless of the elastin proteins that
normally maintain the stability of the aortic wall structure;
this was also indicated by the lower elastin mRNA and
protein level in the dissected aortas.
Other important up-regulating genes were the inflam-
mation genes indicating that the aortic tissues of the af-
fected patients presented an inflammatory response. In a rat
model, the destructive rearrangement of the elastic aortic
Fig 3. Analysis of protein expression patterns of fibulin-1, matrix
metalloproteinase-9 (MMP-9), and elastin at protein levels. Rep-
resentative western blot results of control, aortic dissection, and
nondissected tissues was shown. Here, -actin was used as house-
keeping protein, which was assessed for the relative protein abun-
dance in the three groups of tissues.wall components is preceded by a period of inflammatory wesponse followed by a longer phase of gradual aortic
ilatation.19 Thus, the inflammatory response may play a
ole in the destructive elastic layer. A number of cell adhe-
ion proteins and receptors also demonstrated decreased
xpression in dissected aortas, suggesting that cell adhesion
ight be reduced in affected patients.
Although the collagen content of the dissected aortic
all has been the subject of extensive study, there are still
onflicting reports. We found that not all collagen types
ere down-regulated as illustrated in the other two mi-
roarray studies.12,15 However, type I and III collagens are
he predominant fiber-forming species in the aortic wall, in
hich type I is believed to impart arterial stiffness, whereas
ype III is associated with extensibility of the vessel wall.20
deletion mutation of Type-III collagen in mice led to
ortic dissection very early in their life, respectively.21 This
nteresting finding of increased type I and III collagen
ontent in our dissected aortas was consistent with Wang’s
nalysis.18 Wang hypothesized that such high collagen
ontent resulted in decreased arterial distensibility and in-
reased susceptibility to dissection.
Overaccumulated collagen in the aorta may lead to
edial fibrosis. Then, it may obstruct vessels feeding the
rterial wall as well as small intramural vasa vasorum, result-
ng in necrosis of vascular smooth muscle cells and leading
o stiffness and a vulnerability to pulsatile forces, hence
issections.22 In contrast, Müller et al found that the
ollagen content remained unchanged, while the elastin
RNA was decreased in dissected aortas.23 A more recent
tudy found that wall elastin, but not the overall collagen
ontent, is lower in thoracic aortic aneurysmal dissection
issues. These tissues may display lower wall thickness, higher
eak elastic modulus, and a failure in stress and strain com-
ared with control specimens.24 Their findings suggested that
tiffening and reduction in tissue extensibility by elastin con-
ent rather than just wall weakening might be the causes of
neurysm dissection. Nevertheless, it appears that either in-
reased or decreased or unchanged collagen in the aorta may
eaken the aortic wall by altering the elastin pool, and predis-
oses the patient to aortic dissection. The significant discrep-
ncy in the collagen results may be attributed to the hetero-
eneity of the patient groups, age differences, site for dissected
orta collection, and detection methods.
Our study also showed significant apoptotic gene ex-
ression in dissected aortas. Recent studies have demon-
trated that apoptosis is a prominent feature of dissection.25
ome studies have indicated that collagen may actually induce
poptosis in endothelial cells and vascular smooth muscle
ells.26 Therefore, such observations may be the result of
verexpressed collagen, but still needs further investigation.
The similar gene expression patterns in adjacent mac-
oscopic intact and dissected aortic parts of the same pa-
ients suggests that the gene alterations found between
issected aortas and age- and gender-matched normal aor-
as develop before the dissection takes place.
Thus, dissection is more likely to be the end product of a
rocess of degeneration and drastic remodeling of the aortic
all.
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in other microarray studies15,23,27 and the organ donors
were all males with similar ages as aortic dissected patients.
Solid evidence that the mechanical properties and
strength of aortic wall tissue show pronounced age depen-
dency.28,29 A recent pathway analysis using immunology
microarray also has a 28.8-year age difference between
acute aortic dissection patients and their control Marfan
syndrome patients without dissection.27 Thus, our obser-
vation may have merit in which dissected aortas were eval-
uated against normal aortic tissues from comparable age-
and gender-matched healthy cadaveric organ transplant
donors as control preparations. The relative levels of gene
expression found in the dissected tissues were definitely not
age-dependent.
However, it is important to emphasize that only estab-
lished end-stage dissected aortic tissues were collected from
patients with acute emergency surgery in the present study.
An animal model will be essential to evaluate the causal
relationship of the effects of fibulin-1 knockdown or ex-
Fig 4. Densitometric analysis of gene (A) and protein (
(MMP-9), and elastin was conducted. Relative expressio
dividing the expression level of target gents with the exp
Data were personated as the mean  standard deviati
significant value between dissected aortas and control, a
nondissected aortas and control. No statistical difference
nondissected aortas.)pression on aortic elastin and formation of dissection. An- dther limitation of our study is the over representation of
ale subjects.
More than half of the genes of the total altered gene
xpression in the dissected aortas were down-regulated
ompared with normal aortas. This result implies that the
oss of gene function may be critical for the pathogenesis of
ype A aortic dissection.
Existing approaches are generally limited to quantify-
ng mRNA expression in dissected aortas, and posttran-
criptional activity is only captured to a limited extent. We
ound that the small changes in the mRNA expression of
bulin-1 and elastin genes can be synergistically associated
ith significant changes in the activity of the proteins. The
nclusion of protein expression data may enhance the un-
erstanding of the pathologic changes of diseased aortas.
ONCLUSIONS
This study targeted individual genes that exhibit altered
evels of expression in dissected aortas tissues that may be
elated to the pathophysiologic events underlying aortic
pression levels of fibulin-1, matrix metalloproteinase-9
els of interested genes and proteins were calculated by
n level of -actin of the same RNA or protein sample.
D, Aortic dissection. (*P  .001, was the statistical
*P  .001 was the statistical significant value between
und between the expression level of dissected aortas andB) ex
n lev
ressio
on. A
nd *
was foissection. Fibulin-1 and elastin expression were shown to
11
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
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April 20111078 Cheuk and Chengbe down-regulated in the aortic wall of Stanford Type A
aortic dissection patients. An increased in the aortic
MMP-9 enzyme will likely result in the lysing of elastin.
Although direct experimental evidence will be needed to
resolve their causal relationships, a delicate balance of
MMP-9, elastin, and collagen in the aortic wall is clearly
essential for a compliant aorta. Fibulin-1 may play a vital
role in this balance. Failure of the mature elastin assembly in
aortic walls may render patients susceptible to dissection,
and this may elucidate why reduced fibulin-1 and enhanced
MMP-9 levels potentially lead to the prevention of aortic
dissection.
The authors are indebted to the Genome Research
Centre of the University of Hong Kong for the gene chip
hybridization and quality control.
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Volume 53, Number 4 Cheuk and Cheng 1078.e1Table III. List of genes that were differentially expressed
in all freshly dissected aortas and healthy aortas
Gene Name
Fold
change Regulation
Extracellular matrix proteolysis
MMP-1 3.94 up
MMP-2 2.80 up
MMP-9 6.37 up
MMP-11 5.01 up
TIMP-1 3.51 down
TIMP-2 2.23 down
Extracellular matrix protein
Collagen I 3.01 up
Collagen III 2.13 up
Collagen IV 2.63 down
Collagen VI 2.01 up
Collagen VIII 3.59 down
Collagen X 5.29 up
Collagen XI 4.21 up
Elastin 3.51 down
Fibulin-1 4.60 down
Fibulin-5 2.67 down
Glycoprotein 2.50 down
Proteglycan 2.61 down
Polycystin 2 2.01 down
Cell adhesion proteins and receptor
Chemokine (C-X3-C motif) ligand 1 2.44 down
Endothelin receptor type A 3.5 down
FAT tumor suppressor homolog 3 2.82 down
Fibroblast growth factor receptor 2 3.61 down
GABA B receptor 2.05 down
Kinase insert domain protein receptor 2.05 down
Low-density lipoprotein receptor 2.05 down
LPP 2.68 down
Major histocompatibility complex, class
II
3.18 down
Oncostatin M receptor 2.41 down
Receptor accessory protein 1 4.12 down
Selenoprotein P 2.05 down
Adenosine A3 receptor 3.55 up
Cadherin 6 2.71 up
Cadherin 19 2.10 up
CD16a 3.38 up
CD16b 2.66 up
Colony stimulating factor 3 receptor 4.89 up
Ecotropic viral integration site 2A 2.65 up
Fatty acid binding protein 4 3.44 up
Fibronectin receptor 2.12 up
Integrin beta 3 2.29 up
Integrin 	5 2.46 up
Integrin 	7 2.41 up
Integrin 	X 2.15 up
Integrin, beta-like 1 2.19 up
L-selectin 3.12 up
Sortilin-related receptor, L (DLR class) 2.83 up
Tumor necrosis factor receptor
superfamily
6.47 up
Vascular cell adhesion molecule 1 3.06 up
Inflammation
Annexin 1 2.55 up
Chemokine ligand 10 2.25 up
Chemokine ligand 5 2.35 up
Interferon stimulated transcriptional
factor 3
2.21 up
Interleukin-10 2.83 up
Interleukin-2 3.51 up
Interleukin-6 4.25 up
Interleukin-8 3.20 upable III. Continued
ene name
Fold
change Regulation
Leukocyte surface CD53 antigen 2.19 up
Macrophage inhibitory protein-2 2.51 up
Small inducible cytokine subfamily 2 2.13 up
Tumor necrosis factor 	 3.51 up
mmunomodulatory
Gap junction protein, connexin 43 2.53 down
Paired immunoglobulin-like receptor 3.21 down
rowth factors
Endothelin 1 2.35 up
Endothelin 2 3.31 up
Insulin-like growth factor binding
protein
2.66 up
Vascular endothelial growth factor 3.96 up
ytoskeleton proteins
Actin gamma 2 2.08 down
Actin 	2 11.05
Calponin 2.16 down
Filamin 2.13 down
Gelsolin 3.4 down
Kinesin-related protein 1.9 down
Leiomodin 1 3.38 down
Myosin regulatory light chain 2.45 down
Smooth muscle myosin heavy chain 2.33 down
Tropomyosin alpha chain 2.59 down
Vinculin 2.05 down
rotein turnover
Adenine phosphoribosyltransferase 2.33 up
Gutathione S transferase 2.09 up
myc proto-oncogene 2.19 up
Superoxide dismutase 2 3.11 up
Cyclophilin-like 4 3.57 down
Regulator of G protein signaling 5 2.18 down
rotein binding
Ankyrin 2 2.66 up
Immediate early response 3 5.97 up
MARCKS-like 1 4.56 up
Myeloid cell leukemia sequence 1 3.37 up
Phorbol-12-myristate-13-acetate-
induced protein 1
5.43 up
Protein kinase, cAMP-dependent,
regulatory, type II
4.19 up
Leucine carboxyl methyltransferase 2 2.73 down
Regulator of calcineurin 2 2.49 down
Reticulon 1 3.91 down
NA/nucleotide binding
Activating transcription factor 3 4.46 up
Basic helix-loop-helix family, member
e40
3.39 up
FBJ murine osteosarcoma viral
oncogene homolog B5.29
up
FOS-like antigen 1 2.91 up
Hexokinase 2 2.59 up
Myeloid leukemia factor 1 2.65 up
Neuron navigator 3 3.83 up
Nuclear receptor subfamily 4 2.86 up
Thymocyte selection-associated high
mobility group box
2.37 up
tress response
CD9 antigen 2.09 down
Interalpha (globulin) inhibitor H4 2.57 down
Heat shock protein 27kDa 2.21 up
Heat shock protein 40kDa 2.38 up
Heat shock protein 90kDa 5.09 up
Heat shock transcription factor 1 4.51 up
Protein kinase, alpha-1 catalytic
subunit
2.11 upSuperoxide dismutase 2 2.31 up
Tribbles homolog 1 4.21 up
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ene name
Fold
change Regulation
ell cycle
Centromere protein E 2.92 up
Cyclin G2 3.61 up
Cyclin-dependent kinase inhibitor 2B 2.60 up
Heterogenous nuclear
ribonucleoprotein
2.31 up
Kinesin family member C1 2.81 down
ransporter activity
Apolipoprotein D 6.65 up
Ca2 transporting, plasma membrane 2.15 up
Cytochrome P450 3.22 up
Solute carrier family 2 5.22 up
ranslation control
40S ribosomal protein S17 2.09 up
60S ribosomal protein L23 2.10 up
Ribophorin II 3.22 up
Translocated promoter region 2.47 up
ranscription control
Activating transcription factor 3 2.02 up
DNA-directed RNA polymerase II 2.10 up
High mobility group protein 3.1 up
Insulin-like growth factor binding
protein
2.52 up
Ribosomal protein S6 2.91 up
Transucin-like enhancer split 2 2.91 up
Atonal homolog 8 2.85 down
Cdc42 guanine nucleotide exchange
factor
2.65 down
RNA binding protein with multiple
splicing
2.75 down
enes were clustered into different function groups according to their
iological annotation. Based on the gene ontology, genes that code for
xtracellular matrix protein components and regulating elastic fiber assem-
ly, like fibulin-1 and elastin, were down-regulated, while enzymes like
MP-9 and MMP-11 that degrade matrix proteins were up-regulated in
issected aortas. The identification analysis revealed that the up-regulated
enes belong to functional categories such as cell growth and proliferation,
ellular movement, cell-to-cell signaling and interaction, and cell cycle,
hereas the down-regulated genes were represented by functional catego-
ies such as cell movement, antigen presentation, and cell death.Table III. Continued
Gene name
Fold
change Regulation
Cell growth
Angiopoietin-like 2 2.6 up
HtrA serine peptidase 4 2.24 down
Mortality factor 4 like 2 2.38 down
Scinderin 3.97 down
Suppressor of cytokine signaling 2.05 down
Vasomodulator
Prostaglandin I2 2.15 down
Procoagulants
Tissue factor pathway inhibitor 2 2.89 up
Apoptosis
BCL-2 2.35 up
Caspase 7 2.35 up
Caspase recruitment domain family 2.03 up
FOS-like antigen 2 2.01 up
Perforin 1 2.11 up
Serine kinase 3.31 up
Angiogenesis
Endoglin 2.47 down
Vasohibin 1 3.01 down
Vasculogenesis
jun B proto-oncogene 2.38 up
Metabolism/enzyme activity
3-phosphoglycerate dehydrogenase 3.27 down
Albumin 4.18 down
Alcohol dehydragase 6 2.09 down
Alcohol dehydrogenase 2.39 down
Aldehyde dehydrogenase 5 2.31 down
ATPase 3.53 down
cAMP-dependent protein kinase 5.39 down
Electron transfer flavoprotein 2.81 down
Glutamate decarboxylase 2.18 down
Glycerol kinase 3.39 down
LIM domain only 3 2.64 down
Lipase A 2.03 down
Metallothionein 1 3.23 down
NAD(P)H dehydrogenase, quinone 1 2.54 down
Ornithine aminotransferase 2.96 down
Phosphodiesterase 5A 2.91 down
Phospholamban 2.36 down
Phsophatidic acid phosphatase 2.04 down
Protease inhibit 2.96 down
Proteasome 26-s subunit, non-ATPase 2.10 down
Protein phosphatase 1 11.64 down
Regulator of calcineurin 2 2.51 down
Rho-guanine nucleotide exchange
factor
2.73 down
S100 calcium binding protein A2 2.11 down
Sulfotransferase family 2.39 down
Synaptosomal-associated protein 3.56 down
Visinin-like-1 2.12 down
Acid phosphatase 5, tartrate resistant 2.29 up
ADAM metallopeptidase domain 12 7.59 up
Carbohydrate sulfotransferase 2 2.15 up
Dual specificity phosphatase 14 3.49 up
Glutamate-ammonia ligase 2.27 up
Glutathione S-transferase 10.09 up
Heme oxygenase (decycling) 1 7.10 up
Lysyl oxidase-like 2 3.51 up
Membrane metallo-endopeptidase 2.64 up
Neutrophil cytosolic factor 1C
pseudogene
3.88 up
Rho-related BTB domain containing 3 2.31 up
Secretogranin V (7B2 protein) 2.89 up
Serpin peptidase inhibitor, member 2 3.84 up
